GapMind for catabolism of small carbon sources

 

Protein WP_017867767.1 in Lactobacillus pobuzihii E100301

Annotation: NCBI__GCF_000349725.1:WP_017867767.1

Length: 257 amino acids

Source: GCF_000349725.1 in NCBI

Candidate for 26 steps in catabolism of small carbon sources

Pathway Step Score Similar to Id. Cov. Bits Other hit Other id. Other bits
D-sorbitol (glucitol) catabolism sdh med D-sorbitol dehydrogenase (EC 1.1.1.14) (characterized) 40% 96% 171.4 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
4-hydroxybenzoate catabolism badH lo BadH (characterized) 35% 98% 159.8 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
phenylacetate catabolism badH lo BadH (characterized) 35% 98% 159.8 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-phenylalanine catabolism badH lo BadH (characterized) 35% 98% 159.8 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
xylitol catabolism xdhA lo D-xylulose reductase (EC 1.1.1.9) (characterized) 33% 97% 142.9 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
D-xylose catabolism xdhA lo D-xylulose reductase (EC 1.1.1.9) (characterized) 33% 97% 142.9 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
2-deoxy-D-ribonate catabolism deoxyribonate-dehyd lo 2-deoxy-D-ribonate dehydrogenase (characterized) 33% 94% 133.3 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
2-deoxy-D-ribose catabolism deoxyribonate-dehyd lo 2-deoxy-D-ribonate dehydrogenase (characterized) 33% 94% 133.3 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-arabinose catabolism xacB lo L-arabinose 1-dehydrogenase; D-galactose 1-dehydrogenase (EC 1.1.1.46; EC 1.1.1.48) (characterized) 33% 91% 127.1 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
D-galactose catabolism galdh lo L-arabinose 1-dehydrogenase; D-galactose 1-dehydrogenase (EC 1.1.1.46; EC 1.1.1.48) (characterized) 33% 91% 127.1 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
lactose catabolism galdh lo L-arabinose 1-dehydrogenase; D-galactose 1-dehydrogenase (EC 1.1.1.46; EC 1.1.1.48) (characterized) 33% 91% 127.1 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
D-sorbitol (glucitol) catabolism srlD lo sorbitol-6-phosphate dehydrogenase (characterized) 33% 98% 125.9 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-rhamnose catabolism LRA5 lo 2-dehydro-3-deoxy-L-rhamnonate dehydrogenase (NAD(+)); 2-keto-3-deoxy-L-rhamnonate dehydrogenase; KDRDH; L-KDR dehydrogenase; L-KDR 4-dehydrogenase; EC 1.1.1.401 (characterized) 31% 94% 122.9 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
4-hydroxybenzoate catabolism fadB lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
4-hydroxybenzoate catabolism paaH lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-arginine catabolism fadB lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-citrulline catabolism fadB lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-isoleucine catabolism ivdG lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-lysine catabolism fadB lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
phenylacetate catabolism fadB lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
phenylacetate catabolism paaH lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-phenylalanine catabolism fadB lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-phenylalanine catabolism paaH lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-proline catabolism fadB lo 3-hydroxyacyl-CoA dehydrogenase type-2; 17-beta-hydroxysteroid dehydrogenase 10; 17-beta-HSD 10; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase; 3-hydroxyacyl-CoA dehydrogenase type II; Mitochondrial ribonuclease P protein 2; Mitochondrial RNase P protein 2; Scully protein; Type II HADH; EC 1.1.1.35; EC 1.1.1.51; EC 1.1.1.178 (characterized) 32% 97% 118.6 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
D-xylose catabolism xdh lo D-xylose 1-dehydrogenase (EC 1.1.1.175) (characterized) 32% 93% 115.9 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2
L-rhamnose catabolism LRA1 lo L-rhamnose 1-dehydrogenase (NADP(+)); RHAD; EC 1.1.1.377 (characterized) 32% 96% 113.2 diacetyl reductase ((S)-acetoin forming); EC 1.1.1.304 65% 326.2

Sequence Analysis Tools

View WP_017867767.1 at NCBI

Find papers: PaperBLAST

Find functional residues: SitesBLAST

Search for conserved domains

Find the best match in UniProt

Compare to protein structures

Predict transmenbrane helices: Phobius

Predict protein localization: PSORTb

Find homologs in fast.genomics

Fitness BLAST: loading...

Sequence

MTKKVAMITGGAQGIGEAISRRLSQDGFAVAIADLNKEKGSQVAADIEKNGGKAIAVKVD
VSDRDSFFSAVAEVTEKLGSFDVLVNNAGLGPTTPIETITPEMFDKVYHINVAGDIWGIQ
AALEQFRKNNHGGKIINATSQAGVVGNPNLSLYSSTKFAVRGLTQVAARDLAEENITVNA
YAPGIVKTPMMYDIAHQVGQNAGKDDEWGMQTFAKDIALNRLSEPEDVAAAVSFLAGPDS
NYITGQTIEVDGGMQFH

This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.

Links

Downloads

Related tools

About GapMind

Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.

A candidate for a step is "high confidence" if either:

where "other" refers to the best ublast hit to a sequence that is not annotated as performing this step (and is not "ignored").

Otherwise, a candidate is "medium confidence" if either:

Other blast hits with at least 50% coverage are "low confidence."

Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:

GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).

For more information, see:

If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know

by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory